Posted by Neil Hague - memes and headline comments by David Icke Posted on 13 May 2024

Big Pharma have paid UK healthcare organisations £404 million during 2020-2022

Every year, members of the Association of the British Pharmaceutical Industry (“ABPI”) are required to disclose money that has been paid to healthcare organisations. The data is collated and published on Disclosure UK’s website.

Disclosures reveal that pharmaceutical companies have paid UK healthcare organisations £404 million over the three years 2020-2022 – £150 million, or 37%, was made by five pharmaceutical companies: GlaxoSmithKline, Sanofi Aventis, Novartis, Pfizer and AstraZeneca.

There is little detail about what these payments relate to except that they do not relate to research and development activities.

In a previous article, we revealed AstraZeneca paid TV doctors to promote vaccines and downplay vaccine injuries – dubbed ITVGate. Possibly in a similar vein, GlaxoSmithKline has paid journalists for “disease awareness.”

Using the same basis as we used in our previous article for healthcare professionals (“HCPs”), we have aggregated the data in the Disclosure UK database for the years 2020 to 2022 for the Transfer of Values (“ToVs”) from pharmaceutical companies to healthcare organisations (“HCOs”).  ToVs include financial payments and payments in kind.

According to the ABPI Code of Practice:

Although methods of disclosure may vary with some pharmaceutical companies, the vast majority follow ABPI’s definition of HCO, according to ABPI’s guidance notes for 2022 Disclosure UK data.

In the UK, processing of a person’s personal data may be afforded protection from the Data Protection Act and the General Data Protection Regulation (“GDPR”) and so the full extent of payments to HCPs may not be published.

Read more: Big Pharma have paid UK healthcare organisations £404 million during 2020-2022


From our advertisers